ELMD Pengajuan SEC - Electromed, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

1488917

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Electromed, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 26, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 26, 2025 ELECTROMED, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 26, 2025 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
August 26, 2025	EX-99.1	Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results Record quarterly and annual revenues and operating income, marking the eleventh consecutive quarter of year-over-year revenue and operating income growth Exhibit 99.1 Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results Record quarterly and annual revenues and operating income, marking the eleventh consecutive quarter of year-over-year revenue and operating income growth NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologi
August 26, 2025	EX-10.21	Fiscal Year 2026 Officer Bonus Plan Exhibit 10.21 Fiscal Year 2026 Officer Bonus Plan The Personnel and Compensation Committee of the Board of Directors of Electromed, Inc. (the “Company”) has established the Fiscal Year 2026 Officer Bonus Plan (the “Bonus Plan”) for officers of the Company, including its named executive officers. The Bonus Plan is effective for the fiscal year ending June 30, 2026 and provides an opportunity for ea
August 26, 2025	EX-99.2	Electromed, Inc. Investor Presentation August 26, 2025 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies Exhibit 99.2 Electromed, Inc. Investor Presentation August 26, 2025 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies Forward Looking Statements Certain statements in this presentation constitute forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “anticipate,”
August 26, 2025	EX-24.1	Electromed, Inc. Limited Power of Attorney Exhibit 24.1 Electromed, Inc. Limited Power of Attorney The undersigned director of Electromed, Inc., a Minnesota corporation (the “Company”), does hereby make, constitute and appoint James L. Cunniff and Bradley M. Nagel, and each of them, the undersigned’s true and lawful attorneys-in-fact and agents, with power of substitution and resubstitution, for the undersigned and in the undersigned’s nam
August 26, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2025 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to . Commission File number 001-34839
May 29, 2025	EX-1.01	Conflict Minerals Report Exhibit 1.01 Conflict Minerals Report I. Introduction This Conflict Minerals Report (this “Report”) of Electromed, Inc. (“Company,” “we,” “us” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2024 to December 31, 2024. The Rule requires disclosure of certain inform
May 29, 2025	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 001-34839 41-1732920 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 500 Sixth Avenue NW New Prague, MN 56071 (Address of principal executive offic
May 13, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 13, 2025 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
May 13, 2025	EX-99.2	Company Investor Presentation dated May 13, 2025 Exhibit 99.2
May 13, 2025	EX-99.1	Press Release dated May 13, 2025 Exhibit 99.1 Electromed, Inc. Announces Fiscal 2025 Third Quarter Results Strong operational execution results in tenth consecutive quarter of year-over-year revenue and net income growth NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and
May 13, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-3
March 10, 2025	EX-99.1	Electromed, Inc. Announces Share Repurchase Authorization FOR IMMEDIATE RELEASE Electromed, Inc. Announces Share Repurchase Authorization NEW PRAGUE, Minn. (March 10, 2025) – Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that on March 6, 2025, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock. The timing and amount of share repur
March 10, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 6, 2025 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Nu
February 24, 2025	EX-1	Transactions in Securities of the Issuer During the Past 60 Days EX-1 2 ex1to13da413104002022425.htm TRANSACTIONS IN SECURITIES Exhibit 1 Transactions in Securities of the Issuer During the Past 60 Days Nature of the Transaction Securities Purchased/(Sold) Price Per Security($) Date of Purchase/Sale SUMMERS VALUE FUND LP Sale of Common Stock (15,689) 28.7100* 02/20/2025 Sale of Common Stock (1,947) 29.8060^ 02/20/2025 Sale of Common Stock (11,992) 28.1600$ 02/2
February 11, 2025	EX-99.2	\| 1 Investor Presentation Electromed, Inc. Investor Presentation February 11, 2025 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies \| 3 Investor Presentation Electromed – Who We Are Electromed, Inc. is a growing medical device c Exhibit 99.2 \| 1 Investor Presentation Electromed, Inc. Investor Presentation February 11, 2025 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies \| 2 Investor Presentation Forward Looking Statements Certain statements in this press release constitute forward - looking statements as defined in the US Private Securities Litigation Reform Act of 1995 . Forward - looking statement
February 11, 2025	EX-99.1	Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple strategic growth initiatives Exhibit 99.1 Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple strategic growth initiatives NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway cl
February 11, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 11, 2025 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
February 11, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed
November 21, 2024	SC 13D/A	ELMD / Electromed, Inc. / SKARVAN KATHLEEN - SC 13D/A Activist Investment SC 13D/A 1 skarvan24120813da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3) Under the Securities Exchange Act of 1934 ELECTROMED, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Kathleen S. Skarvan 500 Sixth Avenue NW New Prague, MN 56071 952-758-9299 (Name,
November 18, 2024	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 15, 2024 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 18, 2024	EX-3.1	Amended and Restated Bylaws, effective November 15, 2024 (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed November 18, 2024) Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF ELECTROMED, INC. Effective as of November 15, 2024 ARTICLE ONE OFFICES 1.1 Offices. The principal executive office of the corporation shall be 500 6th Ave NW, New Prague, Minnesota 56071, and the corporation may have offices at such other places within or without the State of Minnesota as the Board of Directors shall from time to time determine or the bus
November 13, 2024	SC 13G/A	ELMD / Electromed, Inc. / Winn George H. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409 108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul
November 12, 2024	EX-99.2	\| 1 Investor Presentation Electromed, Inc. Investor Presentation November 12, 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies Exhibit 99.2 \| 1 Investor Presentation Electromed, Inc. Investor Presentation November 12, 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies \| 2 Investor Presentation Forward Looking Statements Certain statements in this press release constitute forward - looking statements as defined in the US Private Securities Litigation Reform Act of 1995 . Forward - looking statement
November 12, 2024	EX-10.1	Form of Non-Qualified Stock Option Agreement under the 2023 Equity Incentive Plan* Exhibit 10.1 ELECTROMED, INC. 2023 EQUITY INCENTIVE PLAN Non-Qualified Stock Option Agreement Under the 2023 Equity Incentive Plan Electromed, Inc., a Minnesota corporation (the “Company”), pursuant to its 2023 Equity Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s Stock to you, the Participant named below. The terms and conditions of the Option Award are s
November 12, 2024	EX-99.1	Electromed, Inc. Announces Fiscal 2025 First Quarter Financial Results Electromed delivers eighth consecutive quarter of year-over-year revenue and profit growth, while continuing to invest in strategic growth initiatives Exhibit 99.1 Electromed, Inc. Announces Fiscal 2025 First Quarter Financial Results Electromed delivers eighth consecutive quarter of year-over-year revenue and profit growth, while continuing to invest in strategic growth initiatives NEW PRAGUE, Minn.-(BUSINESS WIRE) - Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced fina
November 12, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electrome
November 12, 2024	SC 13G/A	ELMD / Electromed, Inc. / Radoff Bradley Louis - AMENDMENT NO. 3 TO THE SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)1 Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Septembe
November 12, 2024	EX-10.2	Form of Restricted Stock Agreement (Employees) under the 2023 Equity Incentive Plan* Exhibit 10.2 ELECTROMED, INC. 2023 EQUITY INCENTIVE PLAN Restricted Stock Agreement (Employees) Electromed, Inc., a Minnesota corporation (the “Company”), pursuant to its 2023 Equity Incentive Plan (the “Plan”), hereby grants to you, the Participant named below, an award of Restricted Stock, whose vesting is subject the satisfaction of service-based conditions. The terms and conditions of this Res
November 12, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 12, 2024 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
October 1, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State
October 1, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
September 11, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 11, 2024 ELECTROMED, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 11, 2024 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fi
September 11, 2024	EX-99.1	Electromed, Inc. Announces Share Repurchase Authorization Exhibit 99.1 Electromed, Inc. Announces Share Repurchase Authorization NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that effective as of September 11, 2024, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock. The new authorization follows
August 27, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to . Commission File number 001-34839 Electromed, Inc.
August 27, 2024	EX-19	Insider Trading Policy Exhibit 19 ELECTROMED, INC. Insider Trading Policy Effective: August 24, 2023 Federal and state securities laws prohibit individuals from trading in the securities of a company while they are aware of material information about that company that is not generally known or available to the public. Such trading is often referred to as “insider trading.” The purpose of this Insider Trading Policy (thi
August 27, 2024	EX-24.1	Powers of Attorney Exhibit 24.1 Electromed, Inc. Limited Power of Attorney The undersigned director of Electromed, Inc., a Minnesota corporation (the “Company”), does hereby make, constitute and appoint James L. Cunniff and Bradley M. Nagel, and each of them, the undersigned’s true and lawful attorneys-in-fact and agents, with power of substitution and resubstitution, for the undersigned and in the undersigned’s nam
August 27, 2024	EX-99.1	Electromed, Inc. Announces Record Fiscal Year 2024 Financial Results Record Q4 and full year financial results Exhibit 99.1 Electromed, Inc. Announces Record Fiscal Year 2024 Financial Results Record Q4 and full year financial results NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2024”) and full year (“FY 2024”) ended June 30, 2024. Q4 FY 2024 Fina
August 27, 2024	EX-99.2	\| 1 Investor Presentation Electromed, Inc. Investor Presentation August 27, 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies \| 3 Investor Presentation Electromed – Who We Are Electromed, Inc. is a growing medical device com Exhibit 99.2 \| 1 Investor Presentation Electromed, Inc. Investor Presentation August 27, 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies \| 2 Investor Presentation Forward Looking Statements Certain statements in this press release constitute forward - looking statements as defined in the US Private Securities Litigation Reform Act of 1995 . Forward - looking statements
August 27, 2024	EX-10.23	Description of Fiscal Year 2025 Officer Bonus Plan* Exhibit 10.23 Fiscal Year 2025 Officer Bonus Plan The Personnel and Compensation Committee of the Board of Directors of Electromed, Inc. (the “Company”) has established the Fiscal Year 2025 Officer Bonus Plan (the “Bonus Plan”) for officers of the Company, including its named executive officers. The Bonus Plan is effective for the fiscal year ending June 30, 2025 and provides an opportunity for ea
August 27, 2024	EX-97	Compensation Recoupment Policy Exhibit 97 ELECTROMED, INC. COMPENSATION RECOUPMENT POLICY A. Policy The Board of Directors (the “Board”) of Electromed, Inc. (the “Company”) believes that it is in the best interests of the Company and its stockholders to maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The Board has therefore adopted th
August 27, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 27, 2024 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
August 7, 2024	EX-99.1	\| 1 Investor Presentation Electromed, Inc. Investor Presentation August 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies \| 3 Investor Presentation Electromed – Who We Are Electromed, Inc. is a growing medical device company Exhibit 99.1 \| 1 Investor Presentation Electromed, Inc. Investor Presentation August 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies \| 2 Investor Presentation Forward Looking Statements Certain statements in this press release constitute forward - looking statements as defined in the US Private Securities Litigation Reform Act of 1995 . Forward - looking statements can
August 7, 2024	EX-99.2	Electromed, Inc. to Participate in the 2024 Canaccord Global Growth Conference Exhibit 99.2 Electromed, Inc. to Participate in the 2024 Canaccord Global Growth Conference 08/5/2024 NEW PRAGUE, Minn.-(BUSINESS WIRE) - Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to atten
August 7, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 7, 2024 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File N
May 30, 2024	EX-1.01	Conflict Minerals Report as required by Items 1.01, 1.02, and 3.01 of this Form SD. Exhibit 1.01 Conflict Minerals Report I. Introduction This Conflict Minerals Report (this “Report”) of Electromed, Inc. (“Company,” “we,” “us” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2023 to December 31, 2023. The Rule requires disclosure of certain inform
May 30, 2024	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 001-34839 (State or other jurisdiction of incorporation) (Commission File Number) 500 Sixth Avenue NW New Prague, MN 56071 (Address of principal executive offices) (Zip Code) Bradley M. Nagel Chief Financial
May 7, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, I
May 7, 2024	EX-99.1	Electromed, Inc. Announces Record Revenue in Fiscal 2024 Third Quarter Growth initiatives drive record revenue Exhibit 99.1 Electromed, Inc. Announces Record Revenue in Fiscal 2024 Third Quarter Growth initiatives drive record revenue NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2024 (“Q3 FY 2024”). Q3 FY 2024 Financial Highlights ● Net re
May 7, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2024 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Numb
May 7, 2024	EX-99.2	Electromed, Inc. Investor Presentation May 2024 NYSE American: ELMD INNOVATION LEADER IN AIRWAY CLEARANCE TECHNOLOGIES Electromed, Inc. is a growing medical device company focused on airway management to help people around the world breathe better, s Exhibit 99.2 Electromed, Inc. Investor Presentation May 2024 NYSE American: ELMD INNOVATION LEADER IN AIRWAY CLEARANCE TECHNOLOGIES Investor Presentation Forward Looking Statements Certain statements in this press release constitute forward - looking statements as defined in the US Private Securities Litigation Reform Act of 1995 . Forward - looking statements can generally be identified by words
February 14, 2024	SC 13G/A	ELMD / Electromed, Inc. / Winn George H. - AMENDMENT NO. 5 TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409 108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
February 13, 2024	EX-99.1	Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter Growth initiatives drive record revenue, improve margins and enhance operational efficiency Exhibit 99.1 Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter Growth initiatives drive record revenue, improve margins and enhance operational efficiency NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three
February 13, 2024	EX-10.3	Form of Restricted Stock Agreement (Non-Employee Directors) under the 2023 Equity Incentive Plan* Exhibit 10.3 ELECTROMED, INC. 2023 EQUITY INCENTIVE PLAN Restricted Stock Agreement (Non-Employee Directors) Electromed, Inc., a Minnesota corporation (the “Company”), pursuant to its 2023 Equity Incentive Plan (the “Plan”), hereby grants to you, the Participant named below, an award of Restricted Stock, whose vesting is subject the satisfaction of service-based conditions. The terms and condition
February 13, 2024	SC 13G/A	ELMD / Electromed, Inc. / Radoff Bradley Louis - AMENDMENT NO. 2 TO THE SCHEDULE 13G Passive Investment SC 13G/A 1 sc13ga209076elmd02142024.htm AMENDMENT NO. 2 TO THE SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)1 Electromed, Inc. (Name of Issuer) Common Stock, par value $0.0
February 13, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 13, 2024 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
February 13, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed
February 13, 2024	EX-99.2	Electromed, Inc. Investor Presentation February 2024 NYSE American: ELMD INNOVATION LEADER IN AIRWAY CLEARANCE TECHNOLOGIES Electromed, Inc. is a growing medical device company focused on airway management to help people around the world breathe bett Exhibit 99.2 Electromed, Inc. Investor Presentation February 2024 NYSE American: ELMD INNOVATION LEADER IN AIRWAY CLEARANCE TECHNOLOGIES Investor Presentation Forward Looking Statements Certain statements in this press release constitute forward - looking statements as defined in the US Private Securities Litigation Reform Act of 1995 . Forward - looking statements can generally be identified by w
December 15, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 13, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
December 15, 2023	EX-10.2	Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 13, 2023 Exhibit 10.2 RIDER TO BUSINESS LOAN AGREEMENT (ASSET BASED) AND RELATED DOCUMENTS This Rider to Business Loan Agreement (Asset Based) (“Rider”) is attached to and made a part of that certain Business Loan Agreement (Asset Based) dated December 18, 2019 (as amended, restated, supplemented or otherwise modified from time to time, including by this Rider, the “Business Loan Agreement”), referring to
November 30, 2023	EX-4.4	Electromed, Inc. 2023 Equity Incentive Plan (incorporated by reference to Exhibit 4.3 to Registration Statement on Form S-8 filed November 30, 2023)* Exhibit 4.4 ELECTROMED, INC. 2023 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the Electromed, Inc. 2023 Equity Incentive Plan (the “Plan”) is to attract and retain the best available personnel for positions of responsibility with the Company, to provide additional incentives to them and align their interests with those of the Company’s shareholders, and to thereby promote the Company’s long-t
November 30, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 30, 2023 As filed with the Securities and Exchange Commission on November 30, 2023 Registration No.
November 30, 2023	EX-FILING FEES	Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Electromed, Inc.
November 30, 2023	EX-4.3	Electromed, Inc. 2023 Equity Incentive Plan Exhibit 4.3 ELECTROMED, INC. 2023 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the Electromed, Inc. 2023 Equity Incentive Plan (the “Plan”) is to attract and retain the best available personnel for positions of responsibility with the Company, to provide additional incentives to them and align their interests with those of the Company’s shareholders, and to thereby promote the Company’s long-t
November 30, 2023	S-8	As filed with the Securities and Exchange Commission on November 30, 2023 As filed with the Securities and Exchange Commission on November 30, 2023 Registration No.
November 15, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 10, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 15, 2023	EX-99.1	Electromed, Inc. Investor Presentation November 2023 NYSE American: ELMDINNOVATION LEADER IN AIRWAY CLEARANCE TECHNOLOGIES Key Stats:Electromed, Inc. is a growing medical device company focused on airway management to help people around the world bre Exhibit 99.1 Electromed, Inc. Investor Presentation November 2023 NYSE American: ELMDINNOVATION LEADER IN AIRWAY CLEARANCE TECHNOLOGIES Forward Looking Statements Certain statements in this press release constitute forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as ?anticipate,? ?
November 7, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .. Commission File No.: 001-34839 Electrom
November 7, 2023	EX-99.1	Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results Exhibit 99.1 Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2023 (“Q1 FY 2024”). Q1 FY 2024 Financial Highlights ● Net revenue increased 16%
November 7, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
September 26, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy State
September 26, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
August 22, 2023	S-8	As filed with the Securities and Exchange Commission on August 22, 2023 As filed with the Securities and Exchange Commission on August 22, 2023 Registration No.
August 22, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 22, 2023 ELECTROMED, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 22, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
August 22, 2023	EX-10.26	Description of Fiscal Year 2024 Officer Bonus Plan Exhibit 10.26 Fiscal Year 2024 Officer Bonus Plan The Personnel and Compensation Committee of the Board of Directors of Electromed, Inc. (the “Company”) has established the Fiscal Year 2024 Officer Bonus Plan (the “Bonus Plan”) for officers of the Company, including its named executive officers. The Bonus Plan is effective for the fiscal year ending June 30, 2024 and provides an opportunity for ea
August 22, 2023	EX-10.11	Form of Performance Stock Unit Agreement (Inducement Grant)* Exhibit 10.11 ELECTROMED, INC. Performance Stock Unit Agreement (Inducement Grant) Electromed, Inc., a Minnesota corporation (the “Company”), hereby grants an award of Performance Stock Units (“Units”) to you, the Participant named below. The terms and conditions of this Award are set forth in this Performance Stock Unit Agreement (the “Agreement”), consisting of this cover page, the Terms and Con
August 22, 2023	EX-10.12	Form of Non-Qualified Stock Option Agreement (Inducement Grant)* Exhibit 10.12 ELECTROMED, INC. Non-Qualified Stock Option Agreement (Inducement Grant) Electromed, Inc., a Minnesota corporation (the “Company”), pursuant to its 2017 Omnibus Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), to you, the Participant named below. The terms and conditions of the Option Aw
August 22, 2023	EX-99.1	Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results --Record Annual Revenue -- -- Fourth Quarter Revenue Increased 21% Year-Over-Year; Full Year Revenue Increased 15% -- Exhibit 99.1 Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results -Record Annual Revenue - - Fourth Quarter Revenue Increased 21% Year-Over-Year; Full Year Revenue Increased 15% - NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial
August 22, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to . Commission File number 001-34839 Electromed, Inc.
August 22, 2023	EX-FILING FEES	Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Electromed, Inc.
August 22, 2023	EX-24.1	Powers of Attorney Exhibit 24.1 Electromed, Inc. Limited Power of Attorney The undersigned director of Electromed, Inc., a Minnesota corporation (the “Company”), does hereby make, constitute and appoint James L. Cunniff and Bradley M. Nagel, and each of them, the undersigned’s true and lawful attorneys-in-fact and agents, with power of substitution and resubstitution, for the undersigned and in the undersigned’s nam
June 15, 2023	EX-10.1	Letter Agreement with Christopher G. Holland dated as of June 9, 2023* Exhibit 10.1 [*] Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(a)(6). June 9, 2023 BY EMAIL ([]) Christopher Holland [**] Re: Separation From Employment With Electromed Dear Chris, Per our discussions, you and Electromed, Inc. (“Electromed”) have mutually agreed to amicably conclude your employment relationship with Electromed. The purpose of this let
June 15, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 9, 2023 ELECTROMED, INC. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 9, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
June 5, 2023	EX-10.2	Letter Agreement with James Cunniff, dated May 22, 2023 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed June 5, 2023)* Exhibit 10.2 May 22, 2023 James Cunniff (by email: [Redacted]) Dear Jim, In connection with your anticipated employment with Electromed, Inc. (the “Corporation”) under the terms of the Employment Agreement between you and the Corporation effective as of July 1, 2023 (the “Employment Agreement”), we are offering relocation assistance of up to $30,000 (the “Relocation Assistance”), according to the
June 5, 2023	EX-99.1	Electromed Names Jim Cunniff as President and Chief Executive Officer Healthcare Executive Brings More Than 30 Years of Executive Experience and Commercial Success to Electromed Exhibit 99.1 Electromed Names Jim Cunniff as President and Chief Executive Officer Healthcare Executive Brings More Than 30 Years of Executive Experience and Commercial Success to Electromed NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Jim Cunniff as its new Preside
June 5, 2023	EX-10.1	Employment Agreement with James Cunniff, dated May 22, 2023 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed June 5, 2023)* Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made effective as of July 1, 2023 (the “Effective Date”) by and between Electromed, Inc., a Minnesota corporation (the “Corporation”) and James Cunniff, an individual (“Employee”) (collectively “Parties” or individually “Party”). RECITALS WHEREAS, the Corporation desires to employ Employee, and Employee desires to be empl
June 5, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 5, 2023 ELECTROMED, INC. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 5, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
May 31, 2023	EX-1.01	Conflict Minerals Report as required by Items 1.01, 1.02, and 3.01 of this Form SD. Exhibit 1.01 Conflict Minerals Report I. Introduction This Conflict Minerals Report (this “Report”) of Electromed, Inc. (“Company,” “we,” “us” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2022 to December 31, 2022. The Rule requires disclosure of certain inform
May 31, 2023	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 001-34839 (State or other jurisdiction of incorporation) (Commission File Number) 500 Sixth Avenue NW New Prague, MN 56071 (Address of principal executive offices) (Zip Code) Bradley M. Nagel Chief Financial
May 9, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Numb
May 9, 2023	EX-99.1	Electromed, Inc. Announces Fiscal 2023 Third Quarter Results Quarterly Net Revenue Increase of 19% Year-over-Year Exhibit 99.1 Electromed, Inc. Announces Fiscal 2023 Third Quarter Results Quarterly Net Revenue Increase of 19% Year-over-Year NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2023 (“Q3 FY 2023”). Q3 FY 2023 Highlights ● Record quarte
May 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, I
February 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed
February 14, 2023	SC 13D/A	ELMD / Electromed, Inc. / SKARVAN KATHLEEN - AMENDMENT NO. 2 TO SCHEDULE 13D Activist Investment SC 13D/A 1 elmd230188sc13da.htm AMENDMENT NO. 2 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 2) Under the Securities Exchange Act of 1934 ELECTROMED, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Kathleen S. Skarvan 500 Sixth Avenue NW New Prague, MN 56071
February 14, 2023	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 14, 2023 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
February 14, 2023	EX-99.2	Electromed Announces CEO Retirement and Succession Plan Exhibit 99.2 Electromed Announces CEO Retirement and Succession Plan NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan will retire as President and Chief Executive Officer with a target effective date on or around July 1, 2023. After her retirement she will serve as a non-employee m
February 14, 2023	SC 13G/A	ELMD / Electromed, Inc. / Radoff Bradley Louis - AMENDMENT NO. 1 TO THE SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)1 Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) December
February 14, 2023	EX-10.1	Letter Agreement with Kathleen S. Skarvan, dated February 14, 2023 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed February 14, 2023)* Exhibit 10.1 February 14, 2023 Kathleen S. Skarvan 2624 30th Avenue Elk Mound, WI 54739 Dear Kathleen: On behalf of the Board of Directors (the “Board”) of Electromed, Inc. (the “Company”), this letter acknowledges receipt of your notice of voluntary resignation as the Company’s President and Chief Executive Officer and as an employee of the Company, effective as of July 1, 2023 (the “Anticipated
February 14, 2023	EX-99.1	Electromed, Inc. Announces Fiscal 2023 Second Quarter Results Growth initiatives help drive record quarterly revenue Exhibit 99.1 Electromed, Inc. Announces Fiscal 2023 Second Quarter Results Growth initiatives help drive record quarterly revenue NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2022 (“Q2 FY 2023”). Q2 FY 2023 Highlights ● Net rev
February 13, 2023	SC 13G/A	ELMD / Electromed, Inc. / PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. Passive Investment SC 13G/A 1 fp0082241-16sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 1)* Electromed, Inc. (Name of Issuer) Common (Title of Class of Securities) 285409108 (CUSIP Number) December 31, 2022 (Dat
November 17, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 11, 2022 ELECTROMED, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 11, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 8, 2022	EX-99.1	Electromed, Inc. Announces Fiscal 2023 First Quarter Results Continued Momentum on Key Growth Initiatives Exhibit 99.1 Electromed, Inc. Announces Fiscal 2023 First Quarter Results Continued Momentum on Key Growth Initiatives NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (?Electromed? or the ?Company?) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2022 (?Q1 FY 2023?). Q1 FY 2023 Financial Hig
November 8, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electrome
November 8, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 8, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
October 24, 2022	EX-99.1	Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer Accomplished medical device leader to fill key strategic role Exhibit 99.1 Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer Accomplished medical device leader to fill key strategic role NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, Inc. (?Electromed? or the ?Company?) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company?s Chief Financia
October 24, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 19, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
October 24, 2022	EX-10.1	Employment Agreement with Bradley M. Nagel, dated October 19, 2022 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed October 24, 2022)* Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (?Agreement?) is made effective as of November 14, 2022 (?Effective Date?) by and between Electromed, Inc., a Minnesota corporation (the ?Corporation?) and Bradley Nagel, an individual residing in Minnesota (?Employee?) (collectively ?Parties? or individually ?Party?). RECITALS WHEREAS, the Corporation desires to employ Employee, and Empl
September 27, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
September 27, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEF 14A 1 elmd221122elmd.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
August 23, 2022	EX-10.24	Description of Fiscal Year 2023 Officer Bonus Plan* Exhibit 10.24 Fiscal Year 2023 Officer Bonus Plan The Personnel and Compensation Committee of the Board of Directors of Electromed, Inc. (the ?Company?) has established the Fiscal Year 2023 Officer Bonus Plan (the ?Bonus Plan?) for officers of the Company, including its named executive officers. The Bonus Plan is effective for the fiscal year ending June 30, 2023 and provides an opportunity for ea
August 23, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2022 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to . Commission File number 001-34839 Electromed, Inc.
August 23, 2022	EX-24.1	Powers of Attorney Exhibit 24.1 Electromed, Inc. Limited Power of Attorney The undersigned director of Electromed, Inc., a Minnesota corporation (the ?Company?), does hereby make, constitute and appoint Kathleen S. Skarvan and Michelle C. Wirtz, and each of them, the undersigned?s true and lawful attorneys-in-fact and agents, with power of substitution and resubstitution, for the undersigned and in the undersigned?s
August 23, 2022	EX-10.13	Non-Competition, Non-Solicitation and Confidentiality Agreement with Christopher G. Holland dated effective February 16, 2022* Exhibit 10.13 NON-COMPETITION, AND NON-SOLICITATION AGREEMENT FOR AT-WILL EMPLOYEE This NON-COMPETITION AND NON-SOLICITATION AGREEMENT (the ?Agreement?) is effective as of the 16thday of February, 2022, by and between Electromed, Inc. (the ?Corporation?) and Christopher Holland (the ?Employee?). RECITALS A. The Employee is commencing employment with the Corporation in a capacity in which the Emplo
August 23, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 23, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
August 23, 2022	EX-10.12	Non-Competition, Non-Solicitation and Confidentiality Agreement with Michelle C. Wirtz dated effective December 20, 2021* Exhibit 10.12 NON-COMPETITION, AND NON-SOLICITATION AGREEMENT FOR AT-WILL EMPLOYEE This NON-COMPETITION AND NON-SOLICITATION AGREEMENT (the ?Agreement?) is effective as of the 20th day ofDec , 2021, by and between Electromed, Inc. (the ?Corporation?) andMichelle Wirtz (the ?Employee?). RECITALS A. The Employee is commencing employment with the Corporation in a capacity in which the Employee may cr
August 23, 2022	EX-99.1	Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results --Record Annual Revenue and Growth Rate -- Fourth Quarter Revenue Increased 19% Year-Over-Year; Full Year Revenue Increased 16.5% -- Leveraging Strategic Investment EX-99.1 2 elmd221013ex99-1.htm PRESS RELEASE DATED AUGUST 23, 2022 Exhibit 99.1 Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results -Record Annual Revenue and Growth Rate - Fourth Quarter Revenue Increased 19% Year-Over-Year; Full Year Revenue Increased 16.5% - Leveraging Strategic Investments to Accelerate Growth - NEW PRAGUE, Minn.-(BUSINESS WIRE)- Electromed, I
July 25, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 25, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Nu
July 25, 2022	EX-10.1	Cooperation Agreement, dated July 25, 2022, by and among Electromed, Inc. and Summers Value Partners LLC and certain of its affiliates signatory thereto (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed July 25, 2022) Exhibit 10.1 COOPERATION AGREEMENT This Cooperation Agreement (this ?Agreement?) is made and entered into as of July 25, 2022 by and among Electromed, Inc. (the ?Company?) and the entities and natural persons set forth in the signature pages hereto (collectively, ?Summers Value?) (each of the Company and Summers Value, a ?Party? to this Agreement, and collectively, the ?Parties?). RECITALS WHEREAS
July 25, 2022	SC 13D/A	ELMD / Electromed, Inc. / Summers Value Fund Lp - AMENDMENT NO. 3 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 3)1 Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) ANDREW SUMMERS SUMMER
July 25, 2022	EX-99.1	COOPERATION AGREEMENT Exhibit 99.1 COOPERATION AGREEMENT This Cooperation Agreement (this ?Agreement?) is made and entered into as of July 25, 2022 by and among Electromed, Inc. (the ?Company?) and the entities and natural persons set forth in the signature pages hereto (collectively, ?Summers Value?) (each of the Company and Summers Value, a ?Party? to this Agreement, and collectively, the ?Parties?). RECITALS WHEREAS
July 25, 2022	EX-99.1	Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director Electromed Also Enters into New Cooperation Agreement with Summers Value Partners and Expands Board to Eight Members Mr. Summers to serve as Vice Chair of the Fi Exhibit 99.1 Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director Electromed Also Enters into New Cooperation Agreement with Summers Value Partners and Expands Board to Eight Members Mr. Summers to serve as Vice Chair of the Finance and Strategy Committee NEW PRAGUE, Minn., July 25, 2022 ? Electromed, Inc. (?Electromed?) (NYSE American: ELMD), a leader in innova
July 12, 2022	SC 13D/A	ELMD / Electromed, Inc. / SKARVAN KATHLEEN - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 1) Under the Securities Exchange Act of 1934 ELECTROMED, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Kathleen S. Skarvan 500 Sixth Avenue NW New Prague, MN 56071 952-758-9299 (Name, Address and Telephone Number of Person Autho
July 11, 2022	SC 13D	ELMD / Electromed, Inc. / SKARVAN KATHLEEN - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ELECTROMED, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Kathleen S. Skarvan 500 Sixth Avenue NW New Prague, MN 56071 952-758-9299 (Name, Address and Telephone Number of Person Authorized to Receive N
June 7, 2022	EX-10.1	Employment Agreement with Michelle C. Wirtz, dated February 21, 2022 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (?Agreement?) is made effective as of February 21, 2022 (?Effective Date?) by and between Electromed, Inc., a Minnesota corporation (the ?Corporation?) and Michelle Wirtz an individual residing in Minnesota (?Employee?) (collectively ?Parties? or individually ?Party?). RECITALS WHEREAS, the Corporation desires to employ Employee pursuant
June 7, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 7, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
June 7, 2022	EX-10.2	Amendment to Employment Agreement with Michelle C. Wirtz, dated June 1, 2022 Exhibit 10.2 AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment to Employment Agreement (?Amendment?) is made effective as of May 31, 2022 (?Effective Date?) by and between Electromed, Inc., a Minnesota corporation (the ?Corporation?) and Michelle Wirtz an individual residing in Minnesota (?Employee?) (collectively ?Parties? or individually ?Party?). RECITALS WHEREAS, the Corporation and Employee ar
May 31, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 001-34839 (State or other jurisdiction of incorporation or organization) (Commission File Number) 500 Sixth Avenue NW New Prague, MN 56071 (Address of principal executive offices) (Zip Code) Michael J. MacCou
May 31, 2022	EX-1.01	Conflict Minerals Report as required by Items 1.01, 1.02, and 3.01 of this Form SD. EX-1.01 2 elmd220689ex1-01.htm CONFLICT MINERALS REPORT Exhibit 1.01 Conflict Minerals Report I. Introduction This Conflict Minerals Report (the “Report”) of Electromed, Inc. (“Company,” “we,” “us” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2021 to December 31, 20
May 26, 2022	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT The undersigned agree that the Statement on Schedule 13G to which this exhibit is attached and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. Date: May 25, 2022 The Ra
May 26, 2022	SC 13G	ELMD / Electromed, Inc. / Radoff Family Foundation - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) May 25, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
May 10, 2022	EX-10.1	Employment Agreement with Christopher G. Holland, dated February 16, 2022 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (?Agreement?) is made effective as of February 16, 2022 (?Effective Date?) by and between Electromed, Inc., a Minnesota corporation (the ?Corporation?) and Christopher Holland, an individual residing in Minnesota (?Employee?) (collectively ?Parties? or individually ?Party?). RECITALS WHEREAS, the Corporation desires to employ Employee, an
May 10, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Numb
May 10, 2022	EX-99.1	Electromed, Inc. Announces Third Quarter Financial Results 15.4% revenue growth while continuing to execute key strategic initiatives Company also announces Chief Financial Officer transition Exhibit 99.1 Electromed, Inc. Announces Third Quarter Financial Results 15.4% revenue growth while continuing to execute key strategic initiatives Company also announces Chief Financial Officer transition NEW PRAGUE, Minn. - May 10, 2022 - (BUSINESS WIRE) - Electromed, Inc. (?Electromed? or the ?Company?) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced
May 10, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, I
February 14, 2022	SC 13G	ELMD / Electromed, Inc. / PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. )* Electromed, Inc. (Name of Issuer) Common (Title of Class of Securities) 285409108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of
February 8, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed
February 8, 2022	EX-99.1	Electromed, Inc. Announces Second Quarter Financial Results -- Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives -- Exhibit 99.1 Electromed, Inc. Announces Second Quarter Financial Results - Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives - New Prague, Minnesota ? February 8, 2022 ? Electromed, Inc. (?Electromed? or the ?Company?) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for its fisc
February 8, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 8, 2022 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
December 17, 2021	EX-10.2	Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, Dated December 17, 2021 (incorporated by reference to Exhibit 10. 1 to Current Report on 8-K filed December 17, 2021) Exhibit 10.2 RIDER TO BUSINESS LOAN AGREEMENT (ASSET BASED) AND RELATED DOCUMENTS This Rider to Business Loan Agreement (Asset Based) (?Rider?) is attached to and made a part of that certain Business Loan Agreement (Asset Based) dated December 18, 2019 (as amended, restated, supplemented or otherwise modified from time to time, including by this Rider, the ?Business Loan Agreement?), referring to
December 17, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 17, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 17, 2021	8-K	Regulation FD Disclosure, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 12, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 9, 2021	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
November 9, 2021	EX-99.1	Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results -- Record quarterly revenue of $10.0 million, 25.0% growth vs. prior year driven by strong growth in home care and institutional markets -- Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results - Record quarterly revenue of $10.0 million, 25.0% growth vs. prior year driven by strong growth in home care and institutional markets - New Prague, Minnesota ? November 9, 2021 ? Electromed, Inc. (?Electromed? or the ?Company?) (NYSE American: ELMD), a leader in innovative airway clearance t
November 9, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electrome
September 30, 2021	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
September 27, 2021	EX-99.1	COOPERATION AGREEMENT Exhibit 99.1 EXECUTION VERSION COOPERATION AGREEMENT This Cooperation Agreement (this ?Agreement?) is made and entered into as of September 24, 2021 by and among Electromed, Inc. (the ?Company?) and the entities and natural persons set forth in the signature pages hereto (collectively, ?Summers Value?) (each of the Company and Summers Value, a ?Party? to this Agreement, and collectively, the ?Part
September 27, 2021	EX-99.1	Electromed, Inc. Announces Nominations of Kathy Tune and Joe Galatowitsch as New Independent Directors Enters into Cooperation Agreement with Summers Value Partners and Announces Formation of Finance and Strategy Committee to Review Value Creation Op Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Nominations of Kathy Tune and Joe Galatowitsch as New Independent Directors Enters into Cooperation Agreement with Summers Value Partners and Announces Formation of Finance and Strategy Committee to Review Value Creation Opportunities Directors Steve Craney and George Winn to Retire from the Board at Upcoming Annual Meeting NEW PRAGUE,
September 27, 2021	EX-10.1	Cooperation Agreement, dated September 24, 2021, by and among Electromed, Inc. and Summers Value Partners LLC and certain of its affiliates signatory thereto Exhibit 10.1 COOPERATION AGREEMENT This Cooperation Agreement (this ?Agreement?) is made and entered into as of September 24, 2021 by and among Electromed, Inc. (the ?Company?) and the entities and natural persons set forth in the signature pages hereto (collectively, ?Summers Value?) (each of the Company and Summers Value, a ?Party? to this Agreement, and collectively, the ?Parties?). RECITALS WH
September 27, 2021	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 24, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fi
September 27, 2021	SC 13D/A	ELMD / Electromed, Inc. / Summers Value Fund Lp - AMENDMENT NO. 2 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 2)1 Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Andrew Summers Summer
September 27, 2021	EX-99.2	JOINT FILING AGREEMENT Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, par value $0.01 per share, of Electromed, Inc., a Minnesota corporation. This Joint F
August 24, 2021	EX-24.1	Powers of Attorney EX-24.1 4 elmd211048ex24-1.htm POWERS OF ATTORNEY Exhibit 24.1 Electromed, Inc. Limited Power of Attorney The undersigned director of Electromed, Inc., a Minnesota corporation (the “Company”), does hereby make, constitute and appoint Kathleen S. Skarvan and Michael J. MacCourt, and each of them, the undersigned’s true and lawful attorneys-in-fact and agents, with power of substitution and resubsti
August 24, 2021	EX-10.18	Description of Fiscal Year 2022 Officer Bonus Plan* Exhibit 10.18 Fiscal Year 2022 Officer Bonus Plan The Personnel and Compensation Committee of the Board of Directors of Electromed, Inc. (the ?Company?) has established the Fiscal Year 2022 Officer Bonus Plan (the ?Bonus Plan?) for officers of the Company, including its named executive officers. The Bonus Plan is effective for the fiscal year ending June 30, 2022 and provides an opportunity for ea
August 24, 2021	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 24, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
August 24, 2021	EX-99.1	Electromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results -- Double-Digit Year over Year Revenue Growth -- -- Strong Operating Cash Flow -- -- Progress on Key Growth Initiatives: Commercial Expansion, Strategic Marketing, Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results - Double-Digit Year over Year Revenue Growth - - Strong Operating Cash Flow - - Progress on Key Growth Initiatives: Commercial Expansion, Strategic Marketing, Research & Development, Infrastructure Investment - - Provides Update on Fiscal 2022 Strategic Priorities - New Prague,
August 24, 2021	10-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to . Commission File number 001-34839 Electromed, Inc. (Exact Name of
August 13, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
August 12, 2021	SC 13D/A	ELMD / Electromed, Inc. / Summers Value Fund Lp - AMENDMENT NO. 1 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 1)1 Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Andrew Summers Summer
August 12, 2021	EX-99.1	JOINT FILING AND SOLICITATION AGREEMENT Exhibit 99.1 JOINT FILING AND SOLICITATION AGREEMENT WHEREAS, certain of the undersigned are shareholders, direct or beneficial, of Electromed, Inc., a Minnesota corporation (the ?Company?); and WHEREAS, Summers Value Fund LP, SVP Deal Fund 1 LP, Summers Value Partners GP LLC, SVP Deal Fund 1 GP LLC, Summers Value Partners LLC and Andrew Summers (together, ?Summers Value?), Robert W. Leasure Jr.,
August 12, 2021	EX-99.2	POWER OF ATTORNEY EX-99.2 3 ex992to13da113104002081221.htm POWERS OF ATTORNEY Exhibit 99.2 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Andrew Summers the undersigned’s true and lawful attorney-in-fact to take any and all action in connection with (i) the undersigned’s beneficial ownership of, or participation in a group with respect to, securities of Electromed
August 9, 2021	EX-99.2	Electromed, Inc. Notifies Customers of Data Privacy Incident EX-99.2 3 elmd21100899-2.htm PRESS RELEASE REGARDING DATA PRIVACY INCIDENT Exhibit 99.2 FOR IMMEDIATE RELEASE Contact Alan Mueller [email protected] 952-758-9299 Electromed, Inc. Notifies Customers of Data Privacy Incident New Prague, Minnesota – August 9, 2021 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD) today announced that it is mailing letters to individuals w
August 9, 2021	8-K	Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 9, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File N
August 9, 2021	EX-99.1	Electromed, Inc. Announces Select Preliminary Unaudited Financial Results for Fourth Quarter Fiscal 2021 EX-99.1 2 elmd21100899-1.htm PRESS RELEASE DATED AUGUST 9, 2021 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Select Preliminary Unaudited Financial Results for Fourth Quarter Fiscal 2021 New Prague, Minnesota – August 9, 2021 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced select prelim
July 19, 2021	EX-99.1	JOINT FILING AGREEMENT EX-99.1 2 ex991to13d1310400207192021.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, par value $0.01 per s
July 19, 2021	SC 13D	ELMD / Electromed, Inc. / Summers Value Fund Lp - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. )1 Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) ANDREW SUMMERS SUMMERS
May 28, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 41-1732920 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 500 Sixth Avenue NW New Prague, MN 56071 (Address of principal executive offices) (Zip Code) Mich
May 28, 2021	EX-1.01	Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. EX-1.01 2 elmd210704ex1-01.htm CONFLICT MINERALS REPORT Exhibit 1.01 Conflict Minerals Report I. Introduction This Conflict Minerals Report (the “Report”) of Electromed, Inc. (“Company,” “we,” “us” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2020 to December 31, 20
May 27, 2021	EX-99.1	Electromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program New Prague, Minnesota ? May 27, 2021 ? Electromed, Inc. (?Electromed? or the ?Company?) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has approved a $3.0 million stock repurchase authorization, effective as o
May 27, 2021	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 27, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
May 11, 2021	EX-99.1	Electromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results -- Second Consecutive Quarter of Year over Year Growth, Continuing Profitability & Positive Cash Flow while Investing in Key Strategic Initiatives -- EX-99.1 2 elmd210663ex99-1.htm PRESS RELEASE DATED MAY 11, 2021 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results - Second Consecutive Quarter of Year over Year Growth, Continuing Profitability & Positive Cash Flow while Investing in Key Strategic Initiatives - New Prague, Minnesota – May 11, 2021 – Electromed, Inc. (“Electromed” or the “Comp
May 11, 2021	10-Q	Quarterly Report - FORM 10-Q FOR QUARTER ENDED MARCH 31, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, I
May 11, 2021	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 11, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
February 16, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409 108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
February 9, 2021	EX-99.1	Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results -- 11.1% Net Revenue Growth, Driven by a 16.1% Increase in Home Care Revenue -- EX-99.1 2 elmd210146ex99-1.htm PRESS RELEASE DATED FEBRUARY 9, 2021 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results - 11.1% Net Revenue Growth, Driven by a 16.1% Increase in Home Care Revenue - New Prague, Minnesota – February 9, 2021 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway cl
February 9, 2021	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 9, 2021 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
February 9, 2021	10-Q	Quarterly Report - FORM 10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed
December 17, 2020	EX-10.2	Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 16, 2020 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed December 17, 2020) Exhibit 10.2 RIDER TO BUSINESS LOAN AGREEMENT (ASSET BASED) AND RELATED DOCUMENTS This Rider to Business Loan Agreement (Asset Based) (“Rider”) is attached to and made a part of that certain Business Loan Agreement (Asset Based) dated December 18, 2019 (as amended, restated, supplemented or otherwise modified from time to time, including by this Rider, the “Business Loan Agreement”), referring to
December 17, 2020	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits - 8-K DATED DECEMBER 16, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 16, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 18, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 13, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 10, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 10, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 10, 2020	EX-99.1	Electromed, Inc. Announces Fiscal 2021 First Quarter Financial Results -- 16.4% Sequential Revenue Growth Driven by Stronger Home Care Revenue -- EX-99.1 2 elmd201642ex99-1.htm PRESS RELEASE DATED NOVEMBER 10, 2020 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2021 First Quarter Financial Results - 16.4% Sequential Revenue Growth Driven by Stronger Home Care Revenue - New Prague, Minnesota – November 10, 2020 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway cleara
November 10, 2020	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electrome
September 29, 2020	8-K	Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits - FORM 8K DATED SEPTEMBER 29, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 29, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fi
September 29, 2020	EX-3.1	Amended and Restated Bylaws, effective September 29, 2020 (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed September 29, 2020) Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF ELECTROMED, INC. Effective as of September 29, 2020 ARTICLE ONE OFFICES 1.1 Offices. The principal executive office of the corporation shall be 500 6th Ave NW, New Prague, Minnesota 56071, and the corporation may have offices at such other places within or without the State of Minnesota as the Board of Directors shall from time to time determine or the bu
September 29, 2020	EX-99.1	Operating Income (in millions) Operating Cash Flow (in millions) Exhibit 99.1 2020 CEO Letter to Shareholders Making life’s important moments possible — one breath at a time.® To My Fellow Shareholders: In a year marked by global turmoil with the onset of the COVID-19 pandemic, the entire Electromed team demonstrated an unwavering commitment to flawlessly manufacturing and delivering our SmartVest® Airway Clearance System. Despite widespread healthcare system d
September 29, 2020	DEFA14A	- DEFA 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
September 29, 2020	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy State
August 25, 2020	10-K	Annual Report - FORM 10-K FOR THE FISCAL YEAR ENDED JUNE 30, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2020 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to . Commission File number 001-34839 Electromed, Inc. (Ex
August 25, 2020	EX-10.21	Description of Fiscal Year 2021 Officer Bonus Plan* Exhibit 10.21 Fiscal Year 2021 Officer Bonus Plan The Personnel and Compensation Committee of the Board of Directors of Electromed, Inc. (the “Company”) has established the Fiscal Year 2021 Officer Bonus Plan (the “Bonus Plan”) for officers of the Company, including its named executive officers. The Bonus Plan is effective for the fiscal year ending June 30, 2021 and provides an opportunity for ea
August 25, 2020	EX-24.1	Powers of Attorney EX-24.1 4 elmd201269ex24-1.htm POWERS OF ATTORNEY Exhibit 24.1 Electromed, Inc. Limited Power of Attorney The undersigned director of Electromed, Inc., a Minnesota corporation (the “Company”), does hereby make, constitute and appoint Kathleen S. Skarvan and Michael J. MacCourt, and each of them, the undersigned’s true and lawful attorneys-in-fact and agents, with power of substitution and resubsti
August 25, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 25, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
August 25, 2020	EX-99.1	Electromed, Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Financial Results -- Record profitability: diluted EPS of $0.47 in fiscal 2020 versus $0.23 in fiscal 2019 -- Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Financial Results - Record profitability: diluted EPS of $0.47 in fiscal 2020 versus $0.23 in fiscal 2019 - New Prague, Minnesota – August 25, 2020 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced finan
May 21, 2020	EX-1.01	Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 Conflict Minerals Report I. Introduction This Conflict Minerals Report (the “Report”) of Electromed, Inc. (“Company,” “we,” “us” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2019 to December 31, 2019. The Rule requires disclosure of certain information
May 21, 2020	SD	- SPECIAL DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 41-1732920 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 500 Sixth Avenue NW New Prague, MN 56071 (Address of principal executive offices) (Zip Code) Jere
May 18, 2020	EX-99.1	Electromed, Inc. Appoints Michael J. MacCourt as Chief Financial Officer EX-99.1 3 elmd200832ex99-1.htm PRESS RELEASE DATED MAY 18, 2020 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Appoints Michael J. MacCourt as Chief Financial Officer New Prague, Minnesota – May 18, 2020 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Micha
May 18, 2020	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 18, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
May 18, 2020	EX-10.1	Employment Agreement with Michael J. MacCourt dated as of May 7, 2020 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed May 18, 2020)* Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made effective as of May 7, 2020 (“Effective Date”) by and between Electromed, Inc., a Minnesota corporation (the “Corporation”) and Michael MacCourt, an individual residing in Minnesota (“Employee”) (collectively “Parties” or individually “Party”). RECITALS WHEREAS, the Corporation desires to employ Employee, and Employe
May 12, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, I
May 12, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 12, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Num
May 12, 2020	EX-99.1	Electromed, Inc. Announces Fiscal 2020 Third Quarter Financial Results -- 18.0% revenue growth from prior year period with net income of $0.7 million -- EX-99.1 2 elmd200791ex99-1.htm PRESS RELEASE DATED MAY 12, 2020 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2020 Third Quarter Financial Results - 18.0% revenue growth from prior year period with net income of $0.7 million - New Prague, Minnesota – May 12, 2020 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance
March 4, 2020	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Nu
March 4, 2020	EX-99.1	Electromed, Inc. Announces CFO Transition Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces CFO Transition New Prague, Minnesota – March 4, 2020 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that CFO Jeremy Brock has elected to pursue other opportunities and the Company and Mr. Brock have established a transition plan. Mr. Brock w
February 11, 2020	EX-99.1	Electromed, Inc. Announces Fiscal 2020 Second Quarter Financial Results -- Net income of $1.2 million driven by 6.7% revenue growth from prior year period and 18.3% operating margin -- Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2020 Second Quarter Financial Results - Net income of $1.2 million driven by 6.7% revenue growth from prior year period and 18.3% operating margin - New Prague, Minnesota – February 11, 2020 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announ
February 11, 2020	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 11, 2020 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
February 11, 2020	10-Q	ELMD / Electromed, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed
February 10, 2020	SC 13D/A	ELMD / Electromed, Inc. / Zenith Sterling Advisers Llc Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Electromed, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 285409108 (CUSIP Number) Zenith Sterling Advisers LLC Attn: Joshua J. Peters 9075 Deer Ridge Drive Bloomington, Illinois 61705 Telephone: 630-901-5972 (Name, A
January 22, 2020	SC 13G/A	ELMD / Electromed, Inc. / Winn George H. - FORM 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409 108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
January 14, 2020	SC 13G	ELMD / Electromed, Inc. / TOCQUEVILLE ASSET MANAGEMENT L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Electromed, Inc (Name of Issuer) Common Stock (Title of Class of Securities) 285409108 (CUSIP Number) Calendar Year 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w
December 17, 2019	EX-10.1	Business Loan Agreement with Choice Financial Group, dated December 18, 2019 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed December 17, 2019) EX-10.1 2 elmd192320ex10-1.htm BUSINESS LOAN AGREEMENT Exhibit 10.1 BUSINESS LOAN AGREEMENT (ASSET BASED) Principal $2,500,000.00 Loan Date 12-18-2019 Maturity 12-18-2020 Loan No 15695 Call / Coll C49 Account *** Officer KPD Initials References in the boxes above are for Lender’s use only and do not limit the applicability of this document to any particular loan or item. Any item above containing
December 17, 2019	EX-10.2	Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 18, 2019 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed December 17, 2019) Exhibit 10.2 RIDER TO BUSINESS LOAN AGREEMENT (ASSET BASED) AND RELATED DOCUMENTS This Rider to Business Loan Agreement (Asset Based) (“Rider”) is attached to and made a part of that certain Business Loan Agreement (Asset Based) dated December 18, 2019 (as amended, restated, supplemented or otherwise modified from time to time, including by this Rider, the “Business Loan Agreement”), referring to
December 17, 2019	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 16, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
December 13, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 9, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
December 6, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 2, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
December 6, 2019	EX-10.2	Amended and Restated Employment Agreement with Jeremy Brock dated as of December 2, 2019 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed December 6, 2019)* Exhibit 10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (“Agreement”) is made effective as of December 2, 2019 (“Effective Date”) by and between Electromed, Inc., a Minnesota corporation (the “Corporation”) and Jeremy T. Brock, an individual residing in Minnesota (“Employee”) (collectively “Parties” or individually “Party”). RECITALS WHEREAS, the Corpo
December 6, 2019	EX-10.1	Amended and Restated Employment Agreement with Kathleen Skarvan dated as of December 2, 2019 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed December 6, 2019)* Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (“Agreement”) is made effective as of December 2, 2019 (“Effective Date”) by and between Electromed, Inc., a Minnesota corporation (the “Corporation”) and Kathleen S. Skarvan, an individual residing in Minnesota (“Employee”) (collectively “Parties” or individually “Party”). RECITALS WHEREAS, the C
November 19, 2019	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 15, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 12, 2019	10-Q	ELMD / Electromed, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electrome
November 12, 2019	EX-99.1	Electromed, Inc. Announces Fiscal 2020 First Quarter Financial Results -- Net income of $1.0 million primarily driven by 14.1% revenue growth from prior year period and 16.2% operating margin -- Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2020 First Quarter Financial Results - Net income of $1.0 million primarily driven by 14.1% revenue growth from prior year period and 16.2% operating margin - New Prague, Minnesota – November 12, 2019 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, to
November 12, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 12, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
September 27, 2019	DEFA14A	ELMD / Electromed, Inc. DEFA14A - - FORM DEFA 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
September 27, 2019	DEF 14A	ELMD / Electromed, Inc. DEF 14A - - FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy State
September 23, 2019	SC 13D/A	ELMD / Electromed, Inc. / Zenith Sterling Advisers Llc Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Electromed, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 285409108 (CUSIP Number) Zenith Sterling Advisers LLC Attn: Joshua J. Peters 9075 Deer Ridge Drive Bloomington, Illinois 61705 Telephone: 630-901-5972 (Name, A
August 27, 2019	EX-10.20	Description of Fiscal Year 2020 Officer Bonus Plan* Exhibit 10.20 Fiscal Year 2020 Officer Bonus Plan The Personnel and Compensation Committee of the Board of Directors of Electromed, Inc. (the “Company”) has established the Fiscal Year 2020 Officer Bonus Plan (the “Bonus Plan”) for officers of the Company, including its named executive officers. The Bonus Plan is effective for the fiscal year ending June 30, 2020 and provides an opportunity for ea
August 27, 2019	EX-24.1	Powers of Attorney Exhibit 24.1 Electromed, Inc. Limited Power of Attorney The undersigned director of Electromed, Inc., a Minnesota corporation (the “Company”), does hereby make, constitute and appoint Kathleen S. Skarvan and Jeremy T. Brock, and each of them, the undersigned’s true and lawful attorneys-in-fact and agents, with power of substitution and resubstitution, for the undersigned and in the undersigned’s n
August 27, 2019	EX-4.1	Description of Securities (incorporated by reference to Exhibit 4.1 to Annual Report on Form 10-K for the fiscal year ended June 30, 2019) Exhibit 4.1 DESCRIPTION OF SECURITIES The following description of the capital stock of Electromed, Inc., a Minnesota corporation (the “Company,”), does not purport to be complete and is subject to and qualified by reference to the Company’s Articles of Incorporation, as amended (the “Articles”), and Bylaws, as amended (the “Bylaws”), and applicable law, including the Minnesota Business Corporatio
August 27, 2019	10-K	ELMD / Electromed, Inc. 10-K - Annual Report - FORM 10K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2019 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to . Commission File number 001-34839 Electromed, Inc. (Ex
August 27, 2019	EX-99.1	Electromed, Inc. Announces Fiscal 2019 Fourth Quarter and Full Year Financial Results -- Fourth quarter results driven by 10.1% year-over-year growth in home care revenue and operating margin improvement to 17.3% -- EX-99.1 2 a191726ex99-1.htm PRESS RELEASE DATED AUGUST 27, 2019 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2019 Fourth Quarter and Full Year Financial Results - Fourth quarter results driven by 10.1% year-over-year growth in home care revenue and operating margin improvement to 17.3% - New Prague, Minnesota – August 27, 2019 – Electromed, Inc. (NYSE American: ELMD), a lea
August 27, 2019	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 27, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
August 15, 2019	EX-99.1	Electromed, Inc. Names John Erb and Greg Fluet to its Board of Directors EX-99.1 2 elmd191692ex99-1.htm PRESS RELEASE DATED AUGUST 15, 2019 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Names John Erb and Greg Fluet to its Board of Directors New Prague, Minnesota – August 15, 2019 – Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, announced today that its Board of Directors has elected each of John L. Erb and Gregory J
August 15, 2019	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 13, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File
June 13, 2019	SC 13D	ELMD / Electromed, Inc. / Zenith Sterling Advisers Llc Activist Investment fp0043216 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Electromed, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 285409108 (CUSIP Number) Zenith Sterling Advisers LLC Attn: Joshua J. Peters 9075 Deer Ridge Drive Bloomington, Illinois 61705 Telephone: 630-901-5972
May 31, 2019	EX-1.01	Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 Conflict Minerals Report I. Introduction This Conflict Minerals Report (the “Report”) of Electromed, Inc. (“Company,” “we,” “us” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2018 to December 31, 2018. The Rule requires disclosure of certain information
May 31, 2019	SD	ELMD / Electromed, Inc. SD - - FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 41-1732920 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 500 Sixth Avenue NW New Prague, MN 56071 (Address of principal executive offices) (Zip Code) Jere
May 7, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission File Numb
May 7, 2019	EX-99.1	Electromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results EX-99.1 2 a191043ex99-1.htm PRESS RELEASE DATED MAY 7, 2019 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results New Prague, Minnesota – May 7, 2019 – Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2019 (Q3 FY 2019). Q3 FY 2019 H
May 7, 2019	EX-10.1	Form of Non-Qualified Option Agreement under the 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q for the quarter ended March 31, 2019)* Exhibit 10.1 ELECTROMED, INC. Non-Qualified Stock Option Agreement Under the 2017 Omnibus Incentive Plan Electromed, Inc., a Minnesota corporation (the “Company”), pursuant to its 2017 Omnibus Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), to you, the Participant named below. The terms and condition
May 7, 2019	10-Q	ELMD / Electromed, Inc. 10-Q Quarterly Report FORM 10-Q - QUARTER ENDED MARCH 31, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, I
February 14, 2019	SC 13G/A	ELMD / Electromed, Inc. / Red Oak Partners, LLC Passive Investment UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 ) Electromed, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat
February 12, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 12, 2019 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
February 12, 2019	EX-99.1	Electromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results -- 15.1% year-over-year increase in revenue -- Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results - 15.1% year-over-year increase in revenue - New Prague, Minnesota – February 12, 2019 – Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2018 (Q2 FY 2019). Q2 FY 2019 Highli
February 12, 2019	10-Q	ELMD / Electromed, Inc. FORM 10Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed
January 31, 2019	SC 13G	ELMD / Electromed, Inc. / TOCQUEVILLE ASSET MANAGEMENT L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Electromed, Inc (Name of Issuer) Common Stock (Title of Class of Securities) 285409108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh
January 14, 2019	SC 13G/A	ELMD / Electromed, Inc. / Winn George H. - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409 108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
December 18, 2018	EX-10.2	Change in Terms Agreement with Choice Financial Group, dated December 18, 2018 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed December 18, 2018) Exhibit 10.2 CHANGE IN TERMS AGREEMENT Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $2,500,000.00 12-18-2018 12-18-2019 15695 4A/C49 * KPD References in the boxes above are for Lender’s use only and do not limit the applicability of this document to any particular loan or item. Any item above containing “*” has been omitted due to text length limitations. Borrower:
December 18, 2018	EX-10.1	Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 18, 2018 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed December 18, 2018) Exhibit 10.1 RIDER TO BUSINESS LOAN AGREEMENT (ASSET BASED) AND RELATED DOCUMENTS This Rider to Business Loan Agreement (Asset Based) (“Rider”) is attached to and made a part of that certain Change in Terms Agreement dated December 18, 2018 (the “Change in Terms Agreement”), referring to that certain original Promissory Note # 15695 dated December 18, 2013 and related to that certain Business Loan
December 18, 2018	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 17, 2018 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
December 12, 2018	SC 13D/A	ELMD / Electromed, Inc. / Craney Stephen H. - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Electromed, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Stephen H. Craney 25340 Sandpiper Lane Winona, Minnesota 55987 (507) 458-5234 (Name, Address and Telephone Number of Person
November 16, 2018	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 16, 2018 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 13, 2018	EX-99.1	Electromed, Inc. Announces Fiscal 2019 First Quarter Financial Results -- 15.4% year-over-year increase in revenue -- EX-99.1 2 a182444ex99-1.htm PRESS RELEASE DATED NOVEMBER 13, 2018 Exhibit 99.1 FOR IMMEDIATE RELEASE Electromed, Inc. Announces Fiscal 2019 First Quarter Financial Results - 15.4% year-over-year increase in revenue - New Prague, Minnesota – November 13, 2018 – Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announc
November 13, 2018	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 13, 2018 ELECTROMED, INC. (Exact Name of Registrant as Specified in Its Charter) Minnesota 001-34839 41-1732920 (State or Other Jurisdiction of Incorporation) (Commission Fil

ELMD / Electromed, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)